Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration
- PMID: 3965239
- DOI: 10.1038/clpt.1985.16
Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration
Abstract
After intravenous infusion of recombinant leukocyte interferon (rIFN-alpha A) to four subjects with an indwelling reservoir, serial serum and cerebrospinal fluid samples were taken over 48 hr and were analyzed for interferon by an enzyme immunoassay method (ELISA). On separate occasions, 18 and 50 X 10(6) of rIFN-alpha A were infused over 10 min. Maximum serum concentrations of rIFN-alpha A ranged from 6720 to 11,000 pg/ml and from 32,900 to 43,400 pg/ml after the 18 and 50 X 10(6) U doses. There was no measurable concentration of rIFN-alpha A in the cerebrospinal fluid of subjects who received 18 X 10(6) U doses. In three of four subjects who received 50 X 10(6) U rIFN-alpha A, concentrations ranged from 17 to 70 pg/ml that were measurable no earlier than 1 hr after the start of the infusion and that in two cases were measurable throughout 24 hr.
Similar articles
-
Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys.J Interferon Res. 1984 Summer;4(3):399-409. doi: 10.1089/jir.1984.4.399. J Interferon Res. 1984. PMID: 6491397
-
Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection.Clin Pharmacol Ther. 1984 May;35(5):722-7. doi: 10.1038/clpt.1984.101. Clin Pharmacol Ther. 1984. PMID: 6713784
-
Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog.J Interferon Res. 1985 Summer;5(3):403-8. doi: 10.1089/jir.1985.5.403. J Interferon Res. 1985. PMID: 4056487
-
Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.Pharm Res. 1988 Aug;5(8):472-6. doi: 10.1023/a:1015957022073. Pharm Res. 1988. PMID: 3244653
-
Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.J Biol Response Mod. 1988 Apr;7(2):115-22. J Biol Response Mod. 1988. PMID: 3129541
Cited by
-
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology.Front Immunol. 2013 Sep 17;4:281. doi: 10.3389/fimmu.2013.00281. Front Immunol. 2013. PMID: 24062747 Free PMC article. Review.
-
Interferon-alpha in malignant and viral diseases. A review.Drugs. 1993 Feb;45(2):177-211. doi: 10.2165/00003495-199345020-00003. Drugs. 1993. PMID: 7681371 Review.
-
Intracerebroventricular Administration of Interferon-Alpha Induced Depressive-Like Behaviors and Neurotransmitter Changes in Rhesus Monkeys.Front Neurosci. 2020 Nov 19;14:585604. doi: 10.3389/fnins.2020.585604. eCollection 2020. Front Neurosci. 2020. PMID: 33328856 Free PMC article.
-
Interferons in multiple sclerosis. A review of the evidence.Drugs. 1992 Dec;44(6):946-62. doi: 10.2165/00003495-199244060-00004. Drugs. 1992. PMID: 1282865 Review.
-
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.Front Neuroendocrinol. 2012 Aug;33(3):315-27. doi: 10.1016/j.yfrne.2012.09.003. Epub 2012 Sep 21. Front Neuroendocrinol. 2012. PMID: 23000204 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources